Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Patent
1995-06-06
1999-06-01
Ketter, James
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
4242441, 530403, A61K 39385, A61K 3909, C07K 14315
Patent
active
059086297
ABSTRACT:
A vaccine capable of protecting a recipient from infection caused by group B Streptococcus. The vaccine provides polysaccharide-protein moieties and contain (a) a group B Streptococcus polysaccharide conjugated to (b) a functional derivative of a group B Streptococcus C protein alpha antigen that retains the ability to elicit protective antibodies against group B Streptococcus. The vaccine may contain only one type of such polysaccharide-protein unit or may contain a mixture of more than one type of unit.
REFERENCES:
patent: 4207414 (1980-06-01), Kasper
patent: 4284537 (1981-08-01), Beachey
patent: 4324887 (1982-04-01), Kasper
patent: 4356170 (1982-10-01), Jennings et al.
patent: 4356263 (1982-10-01), Kasper
patent: 4367221 (1983-01-01), Kasper
patent: 4367222 (1983-01-01), Kasper
patent: 4367223 (1983-01-01), Kasper
patent: 4425330 (1984-01-01), Norcross et al.
patent: 4619828 (1986-10-01), Gordon
patent: 4673574 (1987-06-01), Anderson
patent: 4757134 (1988-07-01), Blake et al.
patent: 4761283 (1988-08-01), Anderson
patent: 4789735 (1988-12-01), Frank et al.
patent: 4830852 (1989-05-01), Marburg et al.
patent: 4902506 (1990-02-01), Anderson et al.
patent: 5302386 (1994-04-01), Kasper et al.
patent: 5648241 (1997-07-01), Michel et al.
Baker, C. J. and Kasper, D. L., "Group B Streptococcal Vaccines," Rev. Inf. Dis. 7(4):458-467 (1985).
Paoletti et al. Immumogenicity of Group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons. Infection and Immunity vol. 64 677-679, 1996.
Madoff et al. Maternal immunization of mice with Group B Streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes. J. Clin. Invest. vol. 94 286-292, 1994.
Anderson, B. E. et al., "A Protective Protein Antigen of Rickettsia rickettsii Has Tandemly Repeated, Near-Identical Sequences", Infect. Immun. 58 (9):2760-2769 (Sep. 1990).
Avery, O. T. et al., "Chemo-Immunological Studies on Conjugated Carbohydrate-Proteins", J. Exp. Med. 54:437-447 (1931).
Baker, C. J. et al., "Immunization of Pregnant Women With A Polysaccharide Vaccine of Group B Streptococcus", New Eng. J. Med. 319(18):1180-1185 (Nov. 1988).
Baker, C. J., "Immunization to Prevent Group B Streptococcal Disease: Victories and Vexations," J. Inf. Dis. 161(5):917-921 (May 1990).
Bevanger, L. et al., "Complete and Incomplete Ibc Protein Fraction in Group B Streptococci", Acta path. microbiol. scand. Sect. B 87:51-54 (1979).
Bevanger, L. et al., "The Ibc Protein Fraction of Group B Streptococci: Characterization of Protein Antigens Extracted by HCl", Acta path. microbiol. scand. Sect. B. 89:205-209 (1981).
Bevanger, L., "Ibc Proteins as Serotype Markers of Group B Streptococci", Acta path. microbiol. immunol. scand. Sect. B 91:231-234 (1983).
Bevanger, L., "The Ibc Proteins of Group B Streptococci: Isolation of the .alpha. and .beta. Antigens by Immunosorbent Chromatography and Test for Human Serum Antibodies Against the Two Antigens", Acta path. microbiol. immunol. scand. Sect. B 93:113-119 (1985).
Bevanger, L. et al., "Mouse-Protective Antibodies Against the Ibc Proteins of Group B Streptococci", Acta path. microbiol. immunol. scand. Sect. B 93:121-124 (1985).
Bevanger, L. et al., "Characterization of the .alpha. antigen of the c proteins of group B streptococci (GBS) using a murine monoclonal antibody", Acta Pathol. Microbiol. Immunol. Scand. 100(1):57-62 (Jan. 1992).
Bittle, J. L. et al., "Vaccines Produced by Conventional Means to Control Major Infectious Diseases of Man and Animals", Adv. Vet. Sci. Comp. Med. 33:1-63 (Feb. 1989).
Brady, L. J. et al., "Identification of Non-Immunoglobulin A-Fc-Binding Forms and Low-Molecular-Weight Secreted Forms of the Group B Streptococcal .beta. Antigen", Infect. Immun. 57(5):1573-1581 (May 1989).
Baker Immunization to prevent Group B Streptococcal disease: Victories and Vexations. J. Infectious Diseases vol. 161 917-921, 1990.
Madoff et al. Protection of neonatal mice from group B streptococcal infection by maternal immunization with Beta C protein. Infection and Immunity vol. 60 pp. 4989-4994, 1992.
Cleat, P. H. et al., "Cloning and Expression in Escherichia coli of the Ibc Protein Genes of Group B Streptococci: Binding of Human Immunoglobulin A to the Beta Antigen", Infect. Immun. 55(5):1151-1155 (1987).
Coleman, R. T. et al., "Prevention of Neonatal Group B Streptococcal Infections: Advances in Maternal Vaccine Development", Obst. Gynec. 80(2):301-309 (Aug. 1992).
Dailey, D. C. et al., "The Phenotypically Variable Surface Protein of Trichomonas vaginalis Has a Single, Tandemly Repeated Immunodominant Epitope", Infect. Immun. 59(6):2083-2088 (Jun. 1991).
Enea, V. et al., "DNA Cloning of Plasmodium falciparum Circumsporozoite Gene: Amino Acid Sequence of Repetitive Epitope", Science 225:628-630 (1984).
Feldman, R. G. et al., "The immune response to the group B streptococcus", Rev. Med. Microbiol. 3(1):52-58 (Jan. 1992).
Ferrieri, P., "Surface-Localized Protein Antigens of Group B Streptococci", Rev. Infect. Dis. 10(Suppl. 2):s363-s366 (Jul.-Aug. 1988).
Fischetti, V. A. et al., "Structure, Function, and Genetics of Streptococcal M Protein", Rev. Infect. Dis. 10(Suppl. 2):s356-s359 (Jul.-Aug. 1988).
Fischetti, V. A. et al., "Common Characteristics of the Surface Proteins from Gram-Positive Cocci", in: Genetics and Molecular Biology of Streptococci, Lactococci, and Enterococci, Dunny, G. M. et al., eds., American Society for Microbiology: Washington, D.C., pp. 290-294 (Jul. 1991).
Heden, L.-O. et al., "Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity", Eur. J. Immunol. 21:1481-1490 (Jun. 1991).
Horensky, D. S. et al., "Generation and Analysis of Group B Streptococcal Alpha C Protein Gene Constructs Containing Variable Numbers of Tandem Repeats", Abstracts of the 93rd General Meeting of the American Society for Microbiology, Session 107, p. 107, Abstract D-68 (May 1993).
Insel, R. A., "Material Immunization to Prevent Neonatal Infections", New Eng. J. Med. 319(18):1219-1220 (Nov. 1988).
Jerlstrom, P. G. et al., "The IgA-binding .beta. antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two binding regions", Mol. Microbiol. 5(4): 843-849 (Apr. 1991).
Kling, D. E. et al., "Group B Streptococus C Protein Alpha Antigen Peptide Heterogeneity", Abstracts of the 93rd General Meeting of the American Society for Microbiology, Session 166, p. 59, Abstract No. B-189 (May 1993).
Kuypers, J. M. et al., "Molecular Analysis of a Region of the Group B Streptococcus Chromosome Involved in Type III Capsule Expression", Infect. Immun. 57(10):3058-3065 (Oct. 1989).
Lagergard, T. et al., "Synthesis and Immunological Properties of Conjugates Composed of Group B Streptococcus Type III Capsular Polysaccharide Covalently Bound to Tetanus Toxoid", Infect. Immun. 58(3):687-694 (Mar. 1990).
Madoff, L. C. et al., "Phenotypic Diversity in the Alpha C Protein of Group B Streptococci", Infect. Immun. 59(8):2638-2644 (Aug. 1991).
Madoff, L. C. et al., "Protection of Neonatal Mice from Group B Streptococcal infection by Maternal Immunization with Beta C Protein", Clin. Res. 40(2):213A (Mar. 1992).
Lerner, R. A. et al., "The Development of Synthetic Vaccines", in: The Biology of Immunologic Disease, Dixon, F. J. et al., eds., Sinauer Associates: Sunderland, MA, pp. 331-338 (1983).
Madoff, L. C. et al., "Partial characterization of C protein antigens of group B Streptococcus", The Lancefield Society 1989 Meeting, Houston, Texas (Sep. 1989).
Madoff, L. C. et al., "A Monoclonal Antibody Identifies a Protective C-Protein Alpha-Antigen Epitope in Group B Streptococci", Infect. Immun., 59(1):204-210 (Jan. 1991).
Madoff, L. C. et al., "The Cloned and Native Beta Antigens of the Group B Streptococcal C Protein: Role in Protective Immunity", in: New Perspectives on Streptococci and Streptococcal Infections, Orefiel, G., ed., Gustav Fischer: New York, pp. 363-
Ausubel Frederick M.
Kasper Dennis L.
Madoff Lawrence C.
Michel James L.
Brigham and Women's Hospital
Brusca John S.
Ketter James
The General Hospital Corporation
LandOfFree
Conjugate vaccine for group B streptococcus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conjugate vaccine for group B streptococcus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugate vaccine for group B streptococcus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-953573